Alkermes ALKS
NASDAQ ALKS
$44.11 +1.14 (+2.65%)
At close: Oct 20, 2026 · 4:00 PM EDT

Alkermes (ALKS) Acquisitions (2011 - 2026)

Updated

Alkermes (ALKS) reported Acquisitions of $8.88 million for FY2019.

Analysis

Alkermes (ALKS) Acquisitions (2011 - 2026) Analysis & Trends

  • The FY2019 figure ranks as the highest annual Acquisitions since FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -17.24 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.21 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Alkermes 7.37 Bn 4.50 Bn 397.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.09 Bn
Dec 31, 2011 -188,000.00
API Access

Alkermes Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=ALKS&period=max&api_key=YOUR_API_KEY